Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. May 28, 2023; 29(20): 3133-3144
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3133
Table 1 Clinicodemographic characteristics of the study patients, n (%)
Characteristic
Total No. of patients (n = 68)
Number of prior eradication failures
1 (n = 47)
2 (n = 15)
3 (n = 6)
Sex (male)20 (29.4)10 (21.3)6 (4.0)4 (66.7)
Age (yr), mean ± SD 49.60 ± 10.5749.94 ± 10.0048.87 ± 12.6548.83 ± 11.27
Height (m), mean ± SD1.63 ± 0.071.62 ± 0.091.64 ± 0.081.68 ± 0.10
Weight (kg), mean ± SD59.52 ± 12.3056.83 ± 12.1963.80 ± 9.9469.92 ± 11.50
BMI (kg/m2), mean ± SD22.31 ± 3.6421.59 ± 3.9823.63 ± 2.0424.63 ± 1.80
Lifestyle factors
Smoking5 (7.3)4 (8.5)0 (0)1 (16.7)
Drinking4 (5.9)0 (0)1 (6.7)3 (50.0)
Symptom
Abdominal pain7 (10.3)5 (10.6)2 (13.3)0 (0)
Bloating6 (8.8)4 (8.5)2 (13.3)0 (0)
Diarrhea1 (1.5)0 (0)1 (6.7)0 (0)
Halitosis1 (1.5)1 (2.1)0 (0)0 (0)
Belching13 (19.1)8 (17.0)3 (20.0)2 (33.4)
Nausea2 (2.9)2 (4.3)0 (0)0 (0)
Bitter taste1 (1.5)1 (2.1)0 (0)0 (0)
Asymptomatic37 (54.4)26 (55.3)7 (46.7)4 (66.7)
Concomitant disease
Diabetes mellitus9 (13.2)8 (17.0)1 (6.7)0 (0)
Hypertension14 (20.6)7 (14.9)5 (33.3)2 (33.4)
Anxiety disorder4 (5.9)1 (2.1)2 (13.3)1 (16.7)
Gastroscopy findings
Atrophic gastritis33 (48.6)27 (57.4)4 (26.7)2 (33.4)
Non-atrophic gastritis24 (35.3)14 (29.8)8 (53.3)2 (33.4)
Peptic ulcer4 (5.9)1 (2.1)1 (6.7)2 (33.4)
Polyp1 (1.5)0 (0)1 (6.7)0 (0)
Not applicable (no gastroscopy done)6 (8.9)5 (10.6)1 (13.3)0 (0)